v3.22.4
STOCKHOLDERS EQUITY (DEFICIT) AND STOCK-BASED COMPENSATION (Details Narrative) - USD ($)
 9 Months Ended 12 Months Ended
May 09, 2022
May 05, 2022
Jan. 14, 2022
Sep. 30, 2022
Dec. 31, 2021
Dec. 31, 2020
Common stock authorized       6,666,667 6,666,667 6,666,667
Common stock par value       $ 0.0001 $ 0.0001 $ 0.0001
Common stock issued during the six months ended September 30, 2022       127,418    
Common stock issued     2,667 294,085 166,667  
Common stock outstanding       294,085 166,667 133,333
Total common stock sale under IPO 2,930,000     97,667    
Stock issued upon conversion       14,832    
Debt principal converted       $ 1,757,333    
Interest accrued       $ 120,429    
Warrants issued to purchase common stock       3,553,211    
StockOptionPlan       $ 151.20 $ 335.40  
Initial Public Offering [Member]            
StockOptionPlan     $ 50,000      
common stock underlying     5,586      
Stock compensation grants       44,414    
Evergreen [Member]            
Warrants issued to purchase common stock       66,511    
Common share issued against notes       6,667    
Maxim Group LLC [Member]            
Underwritten public offering   97,667        
Exercise price   $ 150.00        
Public offering price   $ 150.00        
Underwriters purchased stock   97,667        
Discount to underwriter   7.00%        
Option to purchase description   The Company granted the Representative a 45-day option to purchase up to an additional 14,650 shares and/or Warrants to purchase up to an additional 14,650 shares of common stock to cover over-allotments        
Warrants purchased   14,650        
Proceeds from warrants   $ 4,390        
Underwriting compensation payable warrants       3,907    
Warrants are exercisable price       $ 187.50